External Source

A Phase I/ii Study Of Acalabrutinib, Venetoclax, & Obinutuzumab In R/r And Treatment-naive Mcl

2025 4:43
Synopsis
Austin Kim, MD, Dana-Farber Cancer Institute, Boston, MA, presents the results of the MAVO study (NCT04855695), a Phase I/II ...
Download Options
Choose a download method below. All links open in new tabs.
Service Features Action
SaveFrom
MP4 & MP3 • HD Quality • Browser Extension Available
Download
Security Notice: These are third-party services. We recommend using antivirus software and being cautious of pop-up ads.